This report examines the strengths and weaknesses of New Zealand’s arrangements for prescription medicines. Central to them is the Pharmaceutical Management Agency, Pharmac, a Crown entity. Among OECD member countries, Pharmac is “unique” in combining “clinical, economic and commercial aspects, and decision-making within a fixed budget for subsidising pharmaceuticals.”1 Other member countries commonly separate these roles and may have more open-ended budgets.Perhaps the greatest strength in New Zealand’s arrangements compared to elsewhere is that, from its inception in 1993, Pharmac... Read more
New Zealand’s isolated geography should not fool us. In our interconnected world, no country is an island – at least metaphorically.
What happens in other places affects New Zealand: culturally, politically and economically.
A greater awareness of global affairs helps us make better choices for the future of our country. It enables us to learn from the successes and failures of others. And it allows us to engage with our international peers on areas of mutual and strategic interest.
The New Zealand Initiative research follows international affairs, assesses their significance for New Zealand, and comments on them to help define the nation’s place in the global space.